Opdivo is already approved to treat advanced forms of melanoma, non-small cell lung cancer, kidney cancer and Hodgkin’s lymphoma.
Bladder cancer is the fifth most commonly diagnosed cancer in the U.S., with about 77,000 new diagnoses and more than 16,000 deaths in 2016, according to news release.
More articles on supply chain:
This week’s 5 must-reads for supply chain leaders
A new framework for measuring the true value of drugs: 5 takeaways
Bloomberg: Medtronic arranging sale of medical supplies business
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
